EMEA-001870-PIP01-15-M02
Key facts
| Active substance |
Rimiducid
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0418/2019
|
| PIP number |
EMEA-001870-PIP01-15-M02
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of graft versus host disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Bellicum Pharma Ltd
Tel. +1 8323841100 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|